During the last three months, 4 analysts shared their evaluations of Moderna (NASDAQ: MRNA ), revealing diverse outlooks from ...

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump.

Breakthrough technology that transforms the body into a virus-zapping vaccine factory is poised to revolutionise the fight against COVID-19 but future pandemics and even cancer could be next, ...

Swiss contract drug manufacturer Lonza's plants in the United States and Switzerland are due to make ingredients for 400 million doses of Moderna's COVID-19 vaccine annually, Lonza said on Monday.

The Armenian immigrant and Flagship Pioneering visionary has spent decades turning scientific impossibilities into ...

The amount of equity flowing into companies developing mRNA-based vaccines has significantly declined so far in 2025, ...

Clinical studies suggest these vaccines can generate immunological memory, allowing lymphocytes to respond to tumor ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. recently terminated $500 million in federal funding for ...

The Moderna Innovation and Technology Centre in Harwell, Oxfordshire is now fully operational and Moderna is licensed to ...

The Department of Defense funds biomedical research to ensure military and pandemic preparedness. This includes mRNA vaccine ...

In September 2025, the Russian Federal Medical and Biological Agency announced that its mRNA-based vaccine Enteromix had ...

Preliminary analysis showed the 2025-2026 formula of mNEXSPIKE generated greater than a 16-fold increase in LP.8.1-neutralizing antibodies across age groups Both of Moderna’s COVID-19 vaccines for the ...